Yoonhee Jun

Yoonhee Jun

Auto-generated profile, based on publicly available information

Yoonhee Jun

Division of Infectious Diseases, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 September 2021 in Diagnostics
Verified
Journal Article
Open access
PDF file
IYIn Young Yoo
In Young Yoo
JLJaewoong Lee
Jaewoong Lee
ACAe Ran Choi
Ae Ran Choi
YJYoon Hee Jun
Yoon Hee Jun
HLHwayoung Lee
Hwayoung Lee
YPYeon-Joon Park
Yeon-Joon Park
Recently, the American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention advised against performing the interferon-γ-release assay (IGRA) test for individuals with a low risk of TB, and also recommended retesting low-risk individuals with an initial positive IGRA result. However, to evaluate both sensitivity and specificity of available tests, we compared the performance of the Standard E TB-Feron (TBF) and QuantiFERON-TB Gold Plus (QFT-Plus) assays in healthcare workers (HCWs) and tuberculosis (TB) patients. We also retrospectively investigated diabetes mellitus (DM) comorbidity among the enrolled TB patients. We prospectively collected samples from 177 HCWs and 48 TB patients. The TBF and QFT-Plus tests were performed and analyzed according to the manufacturers’ instructions. We also defined IGRA results between 0.2 and 0.7 IU/mL as ‘borderline’. The agreement rate between TBF and QFT-Plus was 92.0% (207/225) with a Cohen’s kappa value of 0.77 (95% CI, 0.68–0.87). While the majority (26/31, 83.9%) of borderline TBF results were in HCWs, the majority (14/19, 73.7%) of borderline QFT-Plus results were in TB patients. Discordant results were found in 18 samples, with TBF-positive/QFT-Plus-negative or indeterminate results in 11 HCWs and seven TB patients. After resampling from 10 HCWs (seven borderline-positive and three positive results, all <1.0), six reverted to negative. The prevalence of DM comorbidity was very high (35.4%). In summary, TBF showed substantial agreement with the QFT-Plus assay but had a higher positivity rate in both HCWs and TB patients. The negative conversion rate was high (60%) among HCWs whose initial (TB Ag-nil) result was <1.0.

1 January 2020 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
YKYoonjung Kim
Yoonjung Kim
SKShin-Woo Kim
Shin-Woo Kim
KKKi Tae Kwon
Ki Tae Kwon
HCHyun-Ha Chang
Hyun-Ha Chang
YJYoonhee Jun
Yoonhee Jun
JLJung Gyu Lee
Jung Gyu Lee
Kim Y, et al. J Korean Med Sci. 2019 Dec;35(3):e7. https://doi.org/10.3346/jkms.2020.35.e7

10 February 2020 in BMC Musculoskeletal Disorders
Verified
Journal Article
Open access
PDF file
YKYoun Jeong Kim
Youn Jeong Kim
KKKwi Young Kang
Kwi Young Kang
JSJuyoung Shin
Juyoung Shin
YJYoonhee Jun
Yoonhee Jun
SKSang Il Kim
Sang Il Kim
YKYang Ree Kim
Yang Ree Kim
Background: Screening for osteoporosis with dual-energy X-ray absorptiometry (DXA) is recommended for male HIV-infected patients only above the age of 50. Recently, trabecular bone score (TBS) has been introduced as a novel tool to assess bone microarchitecture using DXA of the lumbar spine. Few studies have reported TBS values in HIV-infected individuals younger than 50 years of age. This study compared TBS values in young males infected with HIV and matched controls, and investigated the associations between TBS and demographic parameters, clinical parameters, and bone mineral density (BMD) scores. Methods: A cross-sectional study of BMD and TBS in HIV-infected men (n = 80) aged between 18 and 50 years and age- and sex-matched controls (n = 80) was conducted. Results: The proportion of patients with low BMD (Z-score ≤ − 2) was significantly greater among HIV-infected patients than among matched controls (21.3% [17/80] vs. 8.8% [7/80], p = 0.027). Mean TBS values were significantly lower in HIV-infected patients than in controls (1.41 ± 0.07 vs. 1.45 ± 0.07, p = 0.008). In both groups, TBS values were positively correlated with BMD at the lumbar spine, femoral neck, and total hip (p < 0.001); however, TBS was not correlated with body mass index. In the HIV group, TBS was negatively correlated with the duration of tenofovir disoproxil fumarate(TDF) exposure (p = 0.04). Conclusion: Young men infected with HIV had abnormal bone trabecular microarchitecture, as assessed by both TBS and BMD. TBS values were correlated with both BMD and the duration of TDF exposure.

1 January 2024 in Infection & Chemotherapy
Verified
Journal Article
Open access
YCYunsu Choi
Yunsu Choi
KAKyoung Hwan Ahn
Kyoung Hwan Ahn
SKSOO MIN KIM
SOO MIN KIM
BCBo Youl Choi
Bo Youl Choi
JCJungsoon Choi
Jungsoon Choi
BPBoyoung Park
Boyoung Park
Choi Y, et al. Infect Chemother. 2024 Nov;56:e56. https://doi.org/10.3947/ic.2024.0085

9 January 2020 in Research Square
Verified
Preprint
Open access
PDF file
YKYoun Jeong Kim
Youn Jeong Kim
KKKwi Young Kang
Kwi Young Kang
JSJuyoung Shin
Juyoung Shin
YJYoonhee Jun
Yoonhee Jun
SKSang Il Kim
Sang Il Kim
YKYang Ree Kim
Yang Ree Kim
Background Screening for osteoporosis with dual-energy X-ray absorptiometry (DXA) is recommended for male HIV-infected patients only above the age of 50. Recently, trabecular bone score (TBS) has been introduced as a novel tool to assess bone microarchitecture using DXA of the lumbar spine. Few studies have reported TBS values in HIV-infected individuals younger than 50 years of age. This study compared TBS values in young males infected with HIV and matched controls, and investigated the associations between TBS and demographic parameters, clinical parameters, and bone mineral density (BMD) scores. Methods A cross-sectional study of BMD and TBS in HIV-infected men (n = 80) aged between 18 and 50 years and age- and sex-matched controls (n = 80) was conducted. Results The proportion of patients with low BMD (Z-score ≤−2) was significantly greater among HIV-infected patients than among matched controls (21.3% [17/80] vs. 8.8% [7/80], p = 0.027). Mean TBS values were significantly lower in HIV-infected patients than in controls (1.41 ± 0.07 vs. 1.45 ± 0.07, p = 0.008). In both groups, TBS values were positively correlated with BMD at the lumbar spine, femoral neck, and total hip (p < 0.001); however, TBS was not correlated with body mass index. In the HIV group, TBS was negatively correlated with the duration of tenofovir disoproxil fumarate(TDF) exposure (p = 0.04). Conclusion Young men infected with HIV had abnormal bone trabecular microarchitecture, as assessed by both TBS and BMD. TBS values were correlated with both BMD and the duration of TDF exposure.

13 January 2020 in Research Square
Verified
Preprint
Open access
PDF file
YKYoun Jeong Kim
Youn Jeong Kim
KKKwi Young Kang
Kwi Young Kang
JSJuyoung Shin
Juyoung Shin
YJYoonhee Jun
Yoonhee Jun
SKSang Il Kim
Sang Il Kim
YKYang Ree Kim
Yang Ree Kim
Background Screening for osteoporosis with dual-energy X-ray absorptiometry (DXA) is recommended for male HIV-infected patients only above the age of 50. Recently, trabecular bone score (TBS) has been introduced as a novel tool to assess bone microarchitecture using DXA of the lumbar spine. Few studies have reported TBS values in HIV-infected individuals younger than 50 years of age. This study compared TBS values in young males infected with HIV and matched controls, and investigated the associations between TBS and demographic parameters, clinical parameters, and bone mineral density (BMD) scores. Methods A cross-sectional study of BMD and TBS in HIV-infected men (n = 80) aged between 18 and 50 years and age- and sex-matched controls (n = 80) was conducted. Results The proportion of patients with low BMD (Z-score ≤−2) was significantly greater among HIV-infected patients than among matched controls (21.3% [17/80] vs. 8.8% [7/80], p = 0.027). Mean TBS values were significantly lower in HIV-infected patients than in controls (1.41 ± 0.07 vs. 1.45 ± 0.07, p = 0.008). In both groups, TBS values were positively correlated with BMD at the lumbar spine, femoral neck, and total hip (p < 0.001); however, TBS was not correlated with body mass index. In the HIV group, TBS was negatively correlated with the duration of tenofovir disoproxil fumarate(TDF) exposure (p = 0.04). Conclusion Young men infected with HIV had abnormal bone trabecular microarchitecture, as assessed by both TBS and BMD. TBS values were correlated with both BMD and the duration of TDF exposure.